Hims & Hers Health launched an online weight management service for men in Germany, targeting a market where obesity is prevalent but insurance rarely covers weight-loss medicines. Patients access EU-
reuters · 2026-10-20 06:12
Hims & Hers Health plans to launch legally available peptides in 2026, but analysts remain cautious about near-term revenue growth due to FDA regulatory uncertainties and limited differentiation from
reuters · 2026-08-12 11:32
Hims & Hers Health missed Q1 revenue estimates and posted a loss amid a strategic pivot to branded GLP-1 drugs like Wegovy. The company anticipates returning to profitability by 2027 following a Novo
reuters · 2026-05-11 13:11